Effects of intravenous morphine sulfate and intranasal dexmedetomidine in extremity fractures patients

Not Applicable

• Conditions: Extremity fractures.; Pathological fracture, not elsewhere classified; M84.4

• Registration Number: IRCT20190608043839N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Opoids consumer
Acute extremity fracture
Age Above 18 years old

Exclusion Criteria

Low of consciousnesses
Chronic renal failure
Cirrhosis
Pregnancy
Alcohol use
Heart & vascular disease
Psychotropic drugs use

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of pain after drug administration. Timepoint: After 15, 30, 60 and 120 minutes after drug administration. Method of measurement: Visual Numerical Rating Scale.

Secondary Outcome Measures

Name	Time	Method
Total dosage of the drug. Timepoint: After the end of treatment. Method of measurement: Based on the information in the patient file.